See more : My Size, Inc. (MYSZ.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Claritas Pharmaceuticals, Inc. (CLAZF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Claritas Pharmaceuticals, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Cellnex Telecom, S.A. (CLNXF) Income Statement Analysis – Financial Results
- Ctac N.V. (CTAC.AS) Income Statement Analysis – Financial Results
- Clariant AG (0QJS.L) Income Statement Analysis – Financial Results
- Brockman Mining Limited (0159.HK) Income Statement Analysis – Financial Results
- Colortv Limited (CTV.AX) Income Statement Analysis – Financial Results
Claritas Pharmaceuticals, Inc. (CLAZF)
About Claritas Pharmaceuticals, Inc.
Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 475.18K | 944.40K | 1.55M | 403.63K | 1.65K | 66.05K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.89K | 807.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -18.89K | -807.73 | 0.00 | 475.18K | 944.40K | 1.55M | 403.63K | 1.65K | 66.05K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | -2.06M | 5.79M | 7.75M | 1.67M | 1.62M | 629.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 1.87M | 3.66M | 3.35M | 3.24M | 3.45M | 91.71K | 131.40K | 6.76M | 6.85M | 0.00 | 6.90M | 3.15M | 3.05M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 683.29K | 0.00 | 0.00 | 0.00 | 0.00 | -963.93K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 1.87M | 3.66M | 3.35M | 3.24M | 3.45M | 775.00K | 131.40K | 6.76M | 6.85M | 9.08M | 5.94M | 3.15M | 3.05M | 1.27M | 232.51K | 175.52K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -2.49M | -9.91M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 498.58K | 231.11K | 8.84K | -4.27K | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | -184.00K | 9.45M | 11.10M | 4.92M | 5.07M | 1.40M | 131.40K | 7.00M | 7.14M | 9.35M | 7.50M | 3.02M | 3.29M | 1.27M | 232.51K | 175.52K |
| Cost & Expenses | 0.00 | 0.00 | -184.00K | 9.45M | 11.10M | 4.92M | 5.07M | 1.40M | 131.40K | 7.00M | 7.14M | 9.35M | 7.50M | 3.02M | 3.29M | 1.27M | 232.51K | 175.52K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 116.00 | 601.00 | 31.62K | 113.01K | 179.60K | 39.60K | 1.65K | 149.65K | 174.38K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 225.00K | 209.00K | 153.00K | 16.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 78.43K | 4.11K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | -184.00K | 9.45M | 11.10M | 19.00K | 18.89K | 1.00K | -80.14K | 249.42K | 295.62K | 272.28K | 57.24K | 30.15K | 74.79K | 404.93 | 312.54K | 0.00 |
| EBITDA | 0.00 | 0.00 | -2.79M | -9.50M | 18.14M | -15.44M | -11.40M | -1.40M | -210.94K | -6.28M | -5.90M | -7.53M | -7.04M | -2.99M | -3.62M | -1.27M | -76.24K | -175.52K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,522.70% | 1,334.91% | -733.39% | -1,742.99% | -181,522.55% | -4,768.36% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | -3.28M | -25.88M | -4.59M | -14.50M | -12.00M | -1.40M | -130.79K | -13.64M | -23.13M | -7.41M | -7.09M | -3.02M | -1.24M | -1.27M | -388.78K | -175.52K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2,869.85% | -2,448.77% | -477.19% | -1,757.17% | -183,355.38% | -1,878.99% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | -858.00K | -16.38M | 17.94M | -27.06M | -6.48M | 0.00 | 79.54K | -14.32M | -17.42M | 3.92M | 0.00 | 0.00 | -2.46M | 171.26K | 0.00 | 0.00 |
| Income Before Tax | 0.00 | 0.00 | -674.00K | -25.83M | 6.84M | -31.86M | -11.55M | -1.40M | -51.25K | -20.01M | -24.60M | -3.76M | -7.09M | -3.02M | -3.70M | -1.10M | -388.78K | -175.52K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -4,211.70% | -2,604.41% | -242.00% | -1,757.17% | -183,355.38% | -5,601.65% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | -4.88M | -4.62M | -99.00K | -1.86M | 107.00 | -6.86K | 0.00 | 13.48M | 18.51M | 171.03K | 1.59M | 753.83K | 110.00K | -110.06K | -156.27K | -27.99K |
| Net Income | 0.00 | 0.00 | 4.21M | -21.21M | 6.94M | -31.86M | -11.55M | -1.40M | -51.25K | -20.01M | -24.71M | -22.02M | -8.19M | -3.77M | -3.81M | -989.32K | -388.78K | -147.53K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -4,211.70% | -2,616.47% | -1,418.05% | -2,028.07% | -229,180.91% | -5,768.18% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.17 | -0.95 | 0.64 | -5.13 | -7.86 | -3.07 | -0.47 | -183.89 | -227.04 | -209.42 | -175.88 | -245.99 | -1.11K | -372.20 | -330.32 | -125.35 |
| EPS Diluted | 0.00 | 0.00 | 0.17 | -0.95 | 0.64 | -5.13 | -7.86 | -3.07 | -0.47 | -183.89 | -227.04 | -209.42 | -175.88 | -245.99 | -1.11K | -372.20 | -330.32 | -125.35 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 26.69M | 22.44M | 10.92M | 6.21M | 1.47M | 457.48K | 108.83K | 108.83K | 108.83K | 105.13K | 46.54K | 15.33K | 3.43K | 2.66K | 1.18K | 1.18K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 26.69M | 22.44M | 10.92M | 6.21M | 1.47M | 457.48K | 108.83K | 108.83K | 108.83K | 105.13K | 46.54K | 15.33K | 3.43K | 2.66K | 1.18K | 1.18K |
No news found for: CLAZF
Source: https://incomestatements.info
Category: Stock Reports